• Search Research Projects
  • Search Researchers
  • How to Use
  1. Back to previous page

Cancer specific expression of Cathepsin E in pancreas

Research Project

Project/Area Number 06670531
Research Category

Grant-in-Aid for General Scientific Research (C)

Allocation TypeSingle-year Grants
Research Field Gastroenterology
Research InstitutionFukui Medical School

Principal Investigator

AZUMA Takeshi  Fukui Medical School, Assistant Prot., 医学部附属病院, 講師 (60221040)

Project Period (FY) 1994 – 1995
Project Status Completed (Fiscal Year 1995)
Budget Amount *help
¥2,400,000 (Direct Cost: ¥2,400,000)
Fiscal Year 1995: ¥700,000 (Direct Cost: ¥700,000)
Fiscal Year 1994: ¥1,700,000 (Direct Cost: ¥1,700,000)
KeywordsCathepsin E / Pancreatic cancer
Research Abstract

Ductal cancers of the pancreas frequently express markers of gastrointestinal epithelial cells. Cathepsin E (CTSE) is a non-secretory, intracellular, but non-lysosomal proteinase found in the highest concentration in the superficial epithelial cells of the stomach. The aims of the present study were to examine the expression of CTSE in the pancreas, to establish an assay system of CTSE,and to evaluate the diagnostic usefulness of CTSE in the pancreatic juice. Eleven patients with pancreatic ductal adenocarcinoma, 10 with mucin-producing adenoma, 3 with intraductal papillary hyperplasia, and 43 with chronic pancreatitis were examined. Surgically resected pancreatic tissues were subjected to the immunohistochemistry for CTSE.Pancreatic juice was collected from the patients, and subjected to sandwich enzyme-linked immunosorbent assay (ELISA) and Westem analysis for detecting CTSE.Positive staining for CTSE was observed in pancreatic ductal adenocarcinoma by immunohistochemistry. CTSE was also expressed in mucin-producing adenoma, intraductal papillary hyperplasia, and mucinous hyperplasia. CTSE in the pancreatic juice was present in 8 of 11 patients with pancreatic ductal adenocarcinoma (72.7%), 5 of 10 patients with mucin-producing tumor (50%), 1 of 3 patients with intraductal papillary hyperplasis (33.3%), and 4 of 43 patients with chronic pancreatitis (9.3%). The detection frequency of CTSE in the pancreatic juice was significantly higher in the patients with pancreatic ductal adenocarcinoma than in the patients with chronic pancreatitis. These findings suggest that the expresson of CTSE is associated with the pathogenesis of pancreatic ductal adenocarcinoma, CTSE in the pancreatic juice seems to be a useful marker for the definitive diagnosis, and the CTSE may be expressed at a relatively early stage of multistep carcinogenesis in the pancreas lesions.

Report

(3 results)
  • 1995 Annual Research Report   Final Research Report Summary
  • 1994 Annual Research Report
  • Research Products

    (3 results)

All Other

All Publications (3 results)

  • [Publications] T.Azuma et al: "Expression of cathepsin E in pancreas:A possible tumor marker for pancreas,a preliminary report" Int.J.Cancer. (in press).

    • Description
      「研究成果報告書概要(和文)」より
    • Related Report
      1995 Final Research Report Summary
  • [Publications] T.Azuma, et al: "Expression of cathepsin E in pancreas : A possible tumor marker for pancreas, a preliminary report" Int. J.Cancer. (in press).

    • Description
      「研究成果報告書概要(欧文)」より
    • Related Report
      1995 Final Research Report Summary
  • [Publications] T.Azuma et al: "Expression of cathepsin E in pancreas:A possible tumor marker for pancreas,a preliminary report" Int.J.Cancer. (in press).

    • Related Report
      1995 Annual Research Report

URL: 

Published: 1994-04-01   Modified: 2016-04-21  

Information User Guide FAQ News Terms of Use Attribution of KAKENHI

Powered by NII kakenhi